| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |